CELEX: 62018TA0403
Language: en
Date: 2019-04-11 00:00:00
Title: Case T-403/18: Judgment of the General Court of 11 April 2019 — Pharmadom v EUIPO — Objectif Pharma (WS wellpharma shop) (EU trade mark — Opposition proceedings — Application for EU figurative mark WS wellpharma shop — Earlier national word mark WELL AND WELL — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EU) 2017/1001)

3.6.2019   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 187/77
            
         
      Judgment of the General Court of 11 April 2019 — Pharmadom v EUIPO — Objectif Pharma (WS wellpharma shop)
      (Case T-403/18) (1)
      
      (EU trade mark - Opposition proceedings - Application for EU figurative mark WS wellpharma shop - Earlier national word mark WELL AND WELL - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)
      (2019/C 187/82)
      Language of the case: French
      
         Parties
      
      
         Applicant: Pharmadom (Boulogne-Billancourt, France) (represented by: M.-P. Dauquaire, lawyer)
      
         Defendant: European Union Intellectual Property Office (represented by: S. Pétrequin and A. Folliard-Monguiral, acting as Agents)
      
         Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Objectif Pharma (Vandoeuvre-lès-Nancy, France) (represented by: A. Nappey, lawyer)
      
         Re:
      
      Action brought against the decision of the Fifth Board of Appeal of EUIPO of 23 March 2018 (Case R 1448/2017-5) relating to opposition proceedings between Pharmadom and Objectif Pharma.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  
                     Dismisses the action;
                  
               
            
                  2.
               
               
                  
                     Orders Pharmadom to pay the costs.
                  
               
            
         (1)  OJ C 301, 27.8.2018.